Newest Addition in Line with the Company’s Stated Goal of Expanding its Clinical and Scientific Teams as it Progresses Development and Ultimate Commercialization of its SEAL™ Device to Treat Brain Aneurysms MILPITAS, Calif. , June 18, 2025 /PRNewswire/ — Galaxy Therapeutics, a privately…